CPH fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. It offers dermatology products, hospital acute care products, out-licensed products, and specialty medicine. The company was founded on January 9, 2004 and is headquartered in Mississauga, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
CPH has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company